These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 13763902)

  • 21. Tumors of the nose and throat.
    FIGI FA
    J Indiana State Med Assoc; 1946 Sep; 39():425-8. PubMed ID: 20996185
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical experiences with the cyclic nitrogen mustard phosphamide ester, Endoxan in the treatment of malignant tumors].
    SCHARENBERG P; KAPISCHKE F
    Munch Med Wochenschr; 1962 Jan; 104():134-8. PubMed ID: 14498052
    [No Abstract]   [Full Text] [Related]  

  • 23. Neurogenic tumors of the nose and throat.
    NEW GB
    Ann Otol Rhinol Laryngol; 1947 Mar; 56(1):228. PubMed ID: 20239850
    [No Abstract]   [Full Text] [Related]  

  • 24. [RESULTS WITH TREATMENT OF MALIGNANT TUMORS IN THE FIELD OF OTORHINOLARYNGOLOGY BY A COMBINATION OF SURGERY AND PROPHYLACTIC CHEMOTHERAPY].
    NAKAMURA F; NAKAMURA A
    Chiryo; 1964; 46():887-95. PubMed ID: 14144013
    [No Abstract]   [Full Text] [Related]  

  • 25. [Malignant otorhinolaryngological tumors in children; observations of 10 years].
    RUNGE L
    Arztl Wochensch; 1957 Apr; 12(16):351-3. PubMed ID: 13424435
    [No Abstract]   [Full Text] [Related]  

  • 26. Malignancies of the ear, nose, and throat.
    BREWER DW
    N Y State J Med; 1953 Nov; 53(21):2492-5. PubMed ID: 13099572
    [No Abstract]   [Full Text] [Related]  

  • 27. [The importance of repeated biopsies for the diagnosis of malignant tumors in otorhinolaryngology].
    DWORACEK H; WILTSCHKO A
    Monatsschr Ohrenheilkd Laryngorhinol; 1954; 88(4):315-8. PubMed ID: 13235687
    [No Abstract]   [Full Text] [Related]  

  • 28. [Experiences with endoxan in the treatment of maligant tumors].
    KIRSCHKE W
    Chirurg; 1961 Aug; 32():372-5. PubMed ID: 13756301
    [No Abstract]   [Full Text] [Related]  

  • 29. Tumors of the nose and throat.
    NEW GB; FOSS EL
    Arch Otolaryngol (1925); 1949 Jan; 49(1):86-94. PubMed ID: 18110057
    [No Abstract]   [Full Text] [Related]  

  • 30. Tumors of the nose and the throat.
    NEW GB; FOSS EL
    Arch Otolaryngol (1925); 1945; 42():421-7. PubMed ID: 21012418
    [No Abstract]   [Full Text] [Related]  

  • 31. Tumors of the nose and throat.
    NEW GB; FOSS EL
    Arch Otolaryngol (1925); 1947 Apr; 45(4):483-91. PubMed ID: 20241831
    [No Abstract]   [Full Text] [Related]  

  • 32. Neurogenic tumors of nose and throat.
    NEW GB; DEVINE KD
    Arch Otolaryngol (1925); 1947 Aug; 46(2):163-79. PubMed ID: 20260369
    [No Abstract]   [Full Text] [Related]  

  • 33. The early diagnosis of malignant disease of the ear, nose and throat.
    THORBURN IB
    Clin J; 1947; 76(2):41-6. PubMed ID: 20292964
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of malignant disease with an alkylating agent: review of 100 patients treated with "Endoxan".
    REEVE TS
    Med J Aust; 1961 May; 48(1)():686-9. PubMed ID: 13740326
    [No Abstract]   [Full Text] [Related]  

  • 35. [Malignant tumors of the otorhinolaryngologic organs in children].
    Fotin AV; Pinegina NL
    Vestn Otorinolaringol; 1970; 32(4):73-7. PubMed ID: 5530669
    [No Abstract]   [Full Text] [Related]  

  • 36. [Research with endoxan therapy of tumors in children].
    KOETTGEN U; WOLF M
    Med Klin; 1961 Jan; 56():15-8. PubMed ID: 15445395
    [No Abstract]   [Full Text] [Related]  

  • 37. [170 tumors of malignant evolution in otorhinolaryngology].
    Parga García MJ
    An Otorrinolaringol Ibero Am; 1983; 10(2):115-37. PubMed ID: 6881488
    [No Abstract]   [Full Text] [Related]  

  • 38. [The diphosphopyridine nucleotide blood level as a criterium for controlled dosage of cytostatics E 39 and endoxan in inoperable tumors].
    BOLT W; RITZL F; TOUSSAINT R; ZERLETT G
    Klin Wochenschr; 1960 Jan; 38():71-4. PubMed ID: 13802378
    [No Abstract]   [Full Text] [Related]  

  • 39. [Mitomen and endoxan: prophylactic and palliative treatment in connection with cancer surgery].
    SORENSEN B
    Ugeskr Laeger; 1959 Aug; 121():1241-6. PubMed ID: 13832874
    [No Abstract]   [Full Text] [Related]  

  • 40. [On some causes of delayed diagnosis and retarded hospitalization of patients with malignant tumors of the ENT organs].
    Korolev MF
    Voen Med Zh; 1966 Nov; 11():27-32. PubMed ID: 6001974
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.